Uniqure N.V. (QURE)

$29.10 +1.46 (5.28%)
Market Cap 1.74B
Revenue (ttm) 16.10M
Net Income (ttm) -198.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,235.84%
Debt to Equity Ratio 0.33
Volume 4,093,900
Avg Vol 2,965,210
Day's Range N/A - N/A
Shares Out 63.07M
Stochastic %K 94%
Beta 0.87
Analysts Strong Sell
Price Target $39.27

Company Profile

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial t...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 20 240 6000
Address:
Paasheuvelweg 25, Amsterdam, Netherlands
stu4
stu4 May. 13 at 9:53 AM
$QURE big money bought the offering , lol , at $47 and then Matt K slipped them a Mikey ….and sold 9M dollars worth of stock, knowing his placebo didn’t exist !! lol Who were those BIG MONEY CLOWNS that Matt fcuked over ??? And Matt’s , HITS , just keep on coming , haha
0 · Reply
Kenwonc
Kenwonc May. 13 at 6:30 AM
$QURE few more direct news and the shorts should be running.
0 · Reply
History101
History101 May. 13 at 1:40 AM
$REPL $QURE good article, more pressure to let patients with rare diseases, or hopeless terminal diseases, try whatever they want to combat their illnesses... https://www.theblaze.com/columns/opinion/the-fda-seems-to-care-more-about-celebrities-than-sick-americans
0 · Reply
Ontherag
Ontherag May. 13 at 1:33 AM
$QURE Gonna get approved tomorrow because the FDA corrupt right?
0 · Reply
Ontherag
Ontherag May. 13 at 1:29 AM
$QURE masssssive
0 · Reply
mikesterz7
mikesterz7 May. 12 at 9:47 PM
$REPL $QURE Marty Makary has resigned as commissioner of the Food and Drug Administration after weeks of mounting pressure from the Trump administration. 🔥🔥🔥
0 · Reply
GIG888888888
GIG888888888 May. 12 at 8:39 PM
$QURE yeah this was a nice bull trap, down she goes tomorrow buy the rumor sell the news.
0 · Reply
Ginelle2424
Ginelle2424 May. 12 at 8:23 PM
$QURE 💯💯
0 · Reply
StocktwitsNews
StocktwitsNews May. 12 at 7:31 PM
REPL, QURE Stocks Rise Amid Makary’s Reported Resignation As FDA Chief $REPL $QURE $PPH $IHE https://stocktwits.com/news/equity/markets/repl-qure-stocks-rise-amid-makary-reported-resignation-as-fda-chief/cZXXVRmReiy
0 · Reply
LotOfAction
LotOfAction May. 12 at 7:18 PM
$QURE Added little more
0 · Reply
Latest News on QURE
uniQure price target lowered to $50 from $70 at H.C. Wainwright

2026-05-07T03:31:34.000Z - 6 days ago

uniQure price target lowered to $50 from $70 at H.C. Wainwright

uniQure price target raised to $28 from $14 at Stifel

2026-05-05T15:40:54.000Z - 7 days ago

uniQure price target raised to $28 from $14 at Stifel

uniQure Earnings Call Transcript: Q1 2026

May 5, 2026, 8:30 AM EDT - 7 days ago

uniQure Earnings Call Transcript: Q1 2026

uniQure reports Q1 EPS (85c), consensus (75c)

2026-05-05T11:53:55.000Z - 7 days ago

uniQure reports Q1 EPS (85c), consensus (75c)

uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

May 5, 2026, 7:05 AM EDT - 8 days ago

uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

uniQure price target raised to $37 from $31 at Chardan

2026-04-30T22:15:49.000Z - 12 days ago

uniQure price target raised to $37 from $31 at Chardan

uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington's Disease

Apr 30, 2026, 7:05 AM EDT - 13 days ago

uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington's Disease

uniQure to Announce First Quarter 2026 Financial Results

Apr 28, 2026, 7:05 AM EDT - 15 days ago

uniQure to Announce First Quarter 2026 Financial Results

uniQure price target raised to $10 from $9 at Goldman Sachs

2026-04-20T10:22:30.000Z - 23 days ago

uniQure price target raised to $10 from $9 at Goldman Sachs

uniQure call volume above normal and directionally bullish

2026-04-17T18:45:16.000Z - 25 days ago

uniQure call volume above normal and directionally bullish

uniQure put volume heavy and directionally bearish

2026-04-10T16:35:19.000Z - 4 weeks ago

uniQure put volume heavy and directionally bearish

uniQure put volume heavy and directionally bearish

2026-04-08T15:15:14.000Z - 4 weeks ago

uniQure put volume heavy and directionally bearish

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims

2026-03-24T16:34:35.000Z - 7 weeks ago

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims

uniQure price target lowered to $25 from $31 at Barclays

2026-03-23T09:35:09.000Z - 7 weeks ago

uniQure price target lowered to $25 from $31 at Barclays

uniQure upgraded to Outperform from Neutral at Mizuho

2026-03-10T20:27:50.000Z - 2 months ago

uniQure upgraded to Outperform from Neutral at Mizuho

uniQure upgraded at Mizuho on potential improvement in regulatory outlook

2026-03-10T20:26:57.000Z - 2 months ago

uniQure upgraded at Mizuho on potential improvement in regulatory outlook

uniQure shares positioned for ‘value inflection,’ says H.C. Wainwright

2026-03-10T10:20:33.000Z - 2 months ago

uniQure shares positioned for ‘value inflection,’ says H.C. Wainwright

This biotech's stock is soaring after a ‘polarizing' FDA official is stepping down

Mar 9, 2026, 9:18 AM EDT - 2 months ago

This biotech's stock is soaring after a ‘polarizing' FDA official is stepping down

Federal health officials attacked an Amsterdam-based biotech company seeking approval of a Huntington's disease treatment and accused it of lying

Mar 5, 2026, 6:01 PM EST - 2 months ago

Federal health officials attacked an Amsterdam-based biotech company seeking approval of a Huntington's disease treatment and accused it of lying

FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's disease

Mar 5, 2026, 2:42 PM EST - 2 months ago

FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's disease

Sr. FDA official calls Uniqure's Huntington's disease treatment a failure

Mar 5, 2026, 1:11 PM EST - 2 months ago

Sr. FDA official calls Uniqure's Huntington's disease treatment a failure

FDA official says UniQure fell short on Huntington's trial, defends new study request

Mar 4, 2026, 11:01 PM EST - 2 months ago

FDA official says UniQure fell short on Huntington's trial, defends new study request

uniQure Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 10:30 AM EST - 2 months ago

uniQure Transcript: TD Cowen 46th Annual Health Care Conference

uniQure Earnings Call Transcript: Q4 2025

Mar 2, 2026, 8:00 AM EST - 2 months ago

uniQure Earnings Call Transcript: Q4 2025

FDA tells UniQure study data insufficient for brain disorder therapy application

Mar 2, 2026, 7:22 AM EST - 2 months ago

FDA tells UniQure study data insufficient for brain disorder therapy application

uniQure Announces 2025 Financial Results and Provides Recent Company Updates

Mar 2, 2026, 7:05 AM EST - 2 months ago

uniQure Announces 2025 Financial Results and Provides Recent Company Updates

QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role

Feb 25, 2026, 6:00 PM EST - 2 months ago

QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role

uniQure to Announce 2025 Financial Results

Feb 23, 2026, 7:05 AM EST - 2 months ago

uniQure to Announce 2025 Financial Results

UniQure N.V. (QURE) Securities Fraud: Contact Berger Montague To Discuss Your Rights

Feb 18, 2026, 10:06 AM EST - 2 months ago

UniQure N.V. (QURE) Securities Fraud: Contact Berger Montague To Discuss Your Rights

UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large Losses in uniQure N.V.

Feb 17, 2026, 8:16 AM EST - 3 months ago

UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large Losses in uniQure N.V.

uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

Feb 6, 2026, 7:05 AM EST - 3 months ago

uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

uniQure Announces Type A Meeting Scheduled with FDA

Jan 9, 2026, 7:05 AM EST - 4 months ago

uniQure Announces Type A Meeting Scheduled with FDA

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

Dec 7, 2025, 12:01 PM EST - 5 months ago

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

Dec 4, 2025, 7:05 AM EST - 5 months ago

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

Nov 14, 2025, 4:17 AM EST - 6 months ago

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

uniQure Earnings Call Transcript: Q3 2025

Nov 10, 2025, 8:30 AM EST - 6 months ago

uniQure Earnings Call Transcript: Q3 2025

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 10, 2025, 7:05 AM EST - 6 months ago

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

uniQure to Announce Third Quarter 2025 Financial Results

Nov 6, 2025, 7:05 AM EST - 6 months ago

uniQure to Announce Third Quarter 2025 Financial Results

stu4
stu4 May. 13 at 9:53 AM
$QURE big money bought the offering , lol , at $47 and then Matt K slipped them a Mikey ….and sold 9M dollars worth of stock, knowing his placebo didn’t exist !! lol Who were those BIG MONEY CLOWNS that Matt fcuked over ??? And Matt’s , HITS , just keep on coming , haha
0 · Reply
Kenwonc
Kenwonc May. 13 at 6:30 AM
$QURE few more direct news and the shorts should be running.
0 · Reply
History101
History101 May. 13 at 1:40 AM
$REPL $QURE good article, more pressure to let patients with rare diseases, or hopeless terminal diseases, try whatever they want to combat their illnesses... https://www.theblaze.com/columns/opinion/the-fda-seems-to-care-more-about-celebrities-than-sick-americans
0 · Reply
Ontherag
Ontherag May. 13 at 1:33 AM
$QURE Gonna get approved tomorrow because the FDA corrupt right?
0 · Reply
Ontherag
Ontherag May. 13 at 1:29 AM
$QURE masssssive
0 · Reply
mikesterz7
mikesterz7 May. 12 at 9:47 PM
$REPL $QURE Marty Makary has resigned as commissioner of the Food and Drug Administration after weeks of mounting pressure from the Trump administration. 🔥🔥🔥
0 · Reply
GIG888888888
GIG888888888 May. 12 at 8:39 PM
$QURE yeah this was a nice bull trap, down she goes tomorrow buy the rumor sell the news.
0 · Reply
Ginelle2424
Ginelle2424 May. 12 at 8:23 PM
$QURE 💯💯
0 · Reply
StocktwitsNews
StocktwitsNews May. 12 at 7:31 PM
REPL, QURE Stocks Rise Amid Makary’s Reported Resignation As FDA Chief $REPL $QURE $PPH $IHE https://stocktwits.com/news/equity/markets/repl-qure-stocks-rise-amid-makary-reported-resignation-as-fda-chief/cZXXVRmReiy
0 · Reply
LotOfAction
LotOfAction May. 12 at 7:18 PM
$QURE Added little more
0 · Reply
trendmaker
trendmaker May. 12 at 5:58 PM
$QURE thinking of adding here !
0 · Reply
Reapthewhirlwind69
Reapthewhirlwind69 May. 12 at 5:50 PM
$QURE Increased position here
0 · Reply
Ginelle2424
Ginelle2424 May. 12 at 5:25 PM
$QURE Goodbye Marty - we will not miss you
0 · Reply
LotOfAction
LotOfAction May. 12 at 5:04 PM
$CLPT $QURE
0 · Reply
TICKERTUTOR
TICKERTUTOR May. 12 at 4:47 PM
$REPL $QURE MAKARY’S TIME ATOP FDA OVER, DIAMANTAS NAMED ACTING COMMISSIONER – POLITICO
0 · Reply
Jcljack26
Jcljack26 May. 11 at 11:23 PM
$QURE FDA in a nutshell
0 · Reply
Dkll303
Dkll303 May. 11 at 9:30 PM
$QURE Before end of qtr “ options selling for insiders “ Morgan Stanley moved it up, or their options are worthless , hahah
0 · Reply
jtsxlr
jtsxlr May. 11 at 6:57 PM
$REPL Not worried at all, this just needs to tuck back inside the bollinger bands and consolidate. Patience and a good time to enter or add IMO. GLTA. $QURE , $ONCY
2 · Reply
jtsxlr
jtsxlr May. 11 at 5:59 PM
$ONCY Is it ready to rock? Let's get that FDA approval already. $REPL , $DVLT , , $QURE
0 · Reply
Herrfranz
Herrfranz May. 11 at 5:06 PM
$QURE added 600 shares
0 · Reply
JFais
JFais May. 10 at 10:18 PM
$LQDA- Q1 report tomorrow (took advantage of February's pullback to add back to the position) Avoided the $QURE gap down on FDA rejection, but conversely I also missed out on the rebound (such is life, happy for longs)
1 · Reply
LotOfAction
LotOfAction May. 9 at 8:15 AM
$QURE Not like you can believe what he says but still….
0 · Reply